CATER: Comprehensive Alveolar and Tooth Esthetic Replacement
CATER
1 other identifier
interventional
39
1 country
1
Brief Summary
The purpose of this study is to prospectively evaluate whether including an allogeneic gum graft (PerioDerm\*) during dental implant therapy improves implant health and appearance. On the day of implant surgery, participating subjects will be randomized to either receive or not receive a supplemental gum graft along with the implant. Participating subjects will also be asked to complete a brief (about 15 questions) oral health questionnaire. Participating subjects will return to the clinic about 8 weeks post surgery for digital crown impressions and again at 11-13 weeks after surgery for crown placement. Participating subjects will also return to clinic at 1 year after implant placement for implant evaluation. At this final study appointment, x-rays and a 3D intraoral scan will be obtained for the purpose of measuring alveolar volume. The health of the mucosa surrounding the implant and subject satisfaction will be assessed via bleeding upon probing and completion of a brief questionnaire, respectively.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_3
Started Aug 2019
Typical duration for phase_3
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 25, 2019
CompletedFirst Submitted
Initial submission to the registry
September 5, 2019
CompletedFirst Posted
Study publicly available on registry
September 9, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 20, 2022
CompletedResults Posted
Study results publicly available
February 28, 2025
CompletedFebruary 28, 2025
February 1, 2025
2.9 years
September 5, 2019
September 25, 2024
February 24, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Percent Change in Volume of Alveolar Ridge as Measured by 3D Intraoral Scanning
Volume of the alveolar ridge (percentage change of the volume) as measured by 3D Intraoral scanning
12 months post implant surgery
Secondary Outcomes (3)
Percentage of Implant Survival
12 months post implant surgery
Marginal Bone Levels (MBLs)
12 months post implant surgery
Vertical Tissue Change as Measured by 3D Intraoral Scanning
12 months post surgery
Other Outcomes (1)
Patient Satisfaction
12 months post implant surgery
Study Arms (2)
Implant with prophylactic allograft
EXPERIMENTALImplant placement will be performed with simultaneous placement of the allograft.
Implant without prophylactic allograft
ACTIVE COMPARATORImplant placement will be performed without a graft
Interventions
implant placement with allograft mucosal enhancement
implant placement without allograft mucosal enhancement
Eligibility Criteria
You may qualify if:
- At least 18 years of age
- Willing and able to provide informed consent
- In need of one implant to replace a missing tooth
- At least 20 teeth in good repair and occlusion
- Sufficient bone volume for dental implant placement without required bone augmentation
- Site development (soft and/or bone tissue) performed at least 5 months before implant placement, when required
You may not qualify if:
- Current smoker
- Implant cannot be placed without bone graft
- Unable to pay for crown
- Untreated rampant caries and/or uncontrolled periodontitis
- Absence of adjacent (mesial and/or distal) natural tooth
- Uncontrolled diabetes
- Systemic or local disease or condition that would compromise post-operative healing and/or osseointegration
- use of bisphosphonates
- History of radiation in the head and neck region
- Unable or unwilling to return for follow-up visits
- Unrealistic esthetic or functional demands
- Unlikely to be able to comply with study procedures
- Unwilling or unable to provide informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Illinois at Chicago College of Dentistry
Chicago, Illinois, 60611, United States
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Lyndon Cooper, Dean
- Organization
- Virginia Commonwealth University
Study Officials
- PRINCIPAL INVESTIGATOR
Sandra Al-Tarawneh
University of Illinois at Chicago
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
September 5, 2019
First Posted
September 9, 2019
Study Start
August 25, 2019
Primary Completion
July 1, 2022
Study Completion
December 20, 2022
Last Updated
February 28, 2025
Results First Posted
February 28, 2025
Record last verified: 2025-02
Data Sharing
- IPD Sharing
- Will not share